TY  - GEN
AU  - Mathews,V
AU  - Desire,S
AU  - George,B
AU  - Lakshmi,K M
AU  - Rao,J G
AU  - Viswabandya,A
AU  - Bajel,A
AU  - Srivastava,V M
AU  - Srivastava,A
AU  - Chandy,M
TI  - Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity
SN  - 0887-6924
PY  - 2006///0912
KW  - Adult
KW  - Arsenic Trioxide
KW  - Arsenicals
KW  - administration & dosage
KW  - Chemical and Drug Induced Liver Injury
KW  - complications
KW  - Cohort Studies
KW  - Disease-Free Survival
KW  - Female
KW  - Follow-Up Studies
KW  - Genetic Predisposition to Disease
KW  - Humans
KW  - Incidence
KW  - Leukemia, Promyelocytic, Acute
KW  - diagnosis
KW  - Liver
KW  - drug effects
KW  - Liver Function Tests
KW  - Male
KW  - Methylenetetrahydrofolate Reductase (NADPH2)
KW  - genetics
KW  - Oxides
KW  - Polymorphism, Genetic
KW  - Remission Induction
KW  - Risk Factors
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Letter
UR  - https://doi.org/10.1038/sj.leu.2404165
ER  -